ConductScience.org, home

Paper17560335

Genes that distinguish physiological and pathological angiogenesis.

Seaman S and 5 others. Cancer Cell, 2007. Cited by 337 papers, by iCite.

Cite this record

ConductScience Library. Genes that distinguish physiological and pathological angiogenesis. Papers, record 17560335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560335

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genes that distinguish physiological and pathological angiogenesis.
PubMed
Journal
Cancer Cell
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
337
iCite
Relative citation ratio, by iCite
6.8
iCite
Revised in PubMed
2025-05-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Seaman SSteven
2Stevens JJanine
3Yang MYMi Young
4Logsdon DDaniel
5Graff-Cherry CCari
6St Croix BBrad

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neovascularization, PathologicMajor topic
Neovascularization, PhysiologicMajor topic
Animals
Antigens, CD
B7 Antigens
Biomarkers, Tumor
Cell Line, Tumor
Endothelium, Vascular
Gene Expression Profiling
Liver
Liver Neoplasms, Experimental
Liver Regeneration
Mice
Organ Specificity
Receptors, Immunologic

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z01 BC010486Intramural NIH HHSUnited StatesZ01BC010486PubMed and NIHNIH RePORTER
ZIABC010486NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01515124The Women In Steady Exercise Research (WISER) Survivor TrialBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17560330The potential of new tumor endothelium-specific markers for the development of antivascular therapy.https://conductscience.org/library/papers/17560330

Source PubMed

Download CSV of comments and corrections

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11723929Morphological analysis of neovascularization at early stages of rat splenic autografts in comparison with tumor angiogenesis.Cell Tissue Res1991https://conductscience.org/library/papers/1723929PubMed
22062858Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/2062858PubMed
37686339Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis.Am J Pathol1993https://conductscience.org/library/papers/7686339PubMed
47512751Requirement of vascular integrin alpha v beta 3 for angiogenesis.Science1994https://conductscience.org/library/papers/7512751PubMed
58548761Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro.Cancer Res1996https://conductscience.org/library/papers/8548761PubMed
69122200Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9122200PubMed
79082986Liver regeneration.Science1997https://conductscience.org/library/papers/9082986PubMed
89176498Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors.Nat Med1997https://conductscience.org/library/papers/9176498PubMed
99485208A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis.Eur J Immunol1998https://conductscience.org/library/papers/9485208PubMed
109570800Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.J Neurosci1998https://conductscience.org/library/papers/9570800PubMed
119885575PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis.Mol Cell1998https://conductscience.org/library/papers/9885575PubMed
1210417778Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1.Int J Cancer1999https://conductscience.org/library/papers/10417778PubMed
1315530405Apelin is a novel angiogenic factor in retinal endothelial cells.Biochem Biophys Res Commun2004https://conductscience.org/library/papers/15530405PubMed
1415558010Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry.Nature2004https://conductscience.org/library/papers/15558010PubMed
1515657052Mouse testican-2. Expression, glycosylation, and effects on neurite outgrowth.J Biol Chem2005https://conductscience.org/library/papers/15657052PubMed
1615796714Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3).Biochem J2005https://conductscience.org/library/papers/15796714PubMed
1716061649Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner.Cancer Res2005https://conductscience.org/library/papers/16061649PubMed
1816355214Angiogenesis as a therapeutic target.Nature2005https://conductscience.org/library/papers/16355214PubMed
1916750822Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo.Dev Biol2006https://conductscience.org/library/papers/16750822PubMed
2017167064CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity.FASEB J2007https://conductscience.org/library/papers/17167064PubMed

See all 52 referencesDownload CSV of references

Cited by214

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 337 citations.

PMIDTitleJournalYearIn PapersSource
42151504The vascular niche: an orchestrator of the spatiotemporal dynamics of distant metastasis.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42151504PubMed
42078935Developmental and angiogenic safety profiles of novel pyridine-based chalcone.Front Pharmacol2026https://conductscience.org/library/papers/42078935PubMed
41997128Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature.Cell2026https://conductscience.org/library/papers/41997128PubMed
41993624Anti-cancer immune priming with β-radioligand therapy using a novel high affinity antibody selectively targeting the 4Ig-Isoform of B7-H3.Theranostics2026https://conductscience.org/library/papers/41993624PubMed
41770377CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond.Cancer Metastasis Rev2026https://conductscience.org/library/papers/41770377PubMed
41691491Selective Targeting of Tip Endothelial Cells as a Therapeutic Strategy for Tumor Angiogenesis.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41691491PubMed
41345954A novel immunocytokine promotes T cell- and cytokine-induced killer cell-mediated antitumor immunity via a non-MHC-restricted mechanism in glioblastoma.J Transl Med2025https://conductscience.org/library/papers/41345954PubMed
41317023Doppel as an early-stage biomarker promoting EMT and dissemination in ovarian cancers.Int J Cancer2026https://conductscience.org/library/papers/41317023PubMed
41073827B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors.Cancer Metastasis Rev2025https://conductscience.org/library/papers/41073827PubMed
39847434A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies.J Clin Invest2025https://conductscience.org/library/papers/39847434PubMed
39467936Expression features of targets for anti-glioma CAR-T cell immunotherapy.J Neurooncol2025https://conductscience.org/library/papers/39467936PubMed
39062483Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.Biomolecules2024https://conductscience.org/library/papers/39062483PubMed
38952550Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature.Front Oncol2024https://conductscience.org/library/papers/38952550PubMed
38637557Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.Blood Cancer J2024https://conductscience.org/library/papers/38637557PubMed
38576482Aberrant tumor vasculature. Facts and pitfalls.Front Pharmacol2024https://conductscience.org/library/papers/38576482PubMed
38473402Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors.Cancers (Basel)2024https://conductscience.org/library/papers/38473402PubMed
38426109Endothelial cells in tumor microenvironment: insights and perspectives.Front Immunol2024https://conductscience.org/library/papers/38426109PubMed
38327753B7-H3 Inhibitors in Oncology Clinical Trials: A Review.J Immunother Precis Oncol2024https://conductscience.org/library/papers/38327753PubMed
38322253An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer.Front Immunol2024https://conductscience.org/library/papers/38322253PubMed
38250867New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3.Vaccines (Basel)2024https://conductscience.org/library/papers/38250867PubMed

See all 214 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17560335

GET https://conductscience.org/api/papers/v1/17560335/references?page=2